134 related articles for article (PubMed ID: 2158906)
1. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3',5'-monophosphorothioates.
Butt E; van Bemmelen M; Fischer L; Walter U; Jastorff B
FEBS Lett; 1990 Apr; 263(1):47-50. PubMed ID: 2158906
[TBL] [Abstract][Full Text] [Related]
2. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor.
Butt E; Eigenthaler M; Genieser HG
Eur J Pharmacol; 1994 Oct; 269(2):265-8. PubMed ID: 7851503
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Characterization of 8-Nitroguanosine 3',5'-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α.
Ahmed KA; Zhang T; Ono K; Tsutsuki H; Ida T; Akashi S; Miyata K; Oike Y; Akaike T; Sawa T
Biol Pharm Bull; 2017 Mar; 40(3):365-374. PubMed ID: 27980245
[TBL] [Abstract][Full Text] [Related]
4. cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery.
Kawada T; Toyosato A; Islam MO; Yoshida Y; Imai S
Eur J Pharmacol; 1997 Mar; 323(1):75-82. PubMed ID: 9105879
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
[TBL] [Abstract][Full Text] [Related]
6. Rp-8-Br-guanosine-3',5'-cyclic monophosphorothioate inhibits relaxation elicited by nitroglycerin in rabbit aorta.
Nakazawa M; Imai S
Eur J Pharmacol; 1994 Feb; 253(1-2):179-81. PubMed ID: 8013545
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
8. Starfish oocyte maturation: evidence for a cyclic AMP-dependent inhibitory pathway.
Meijer L; Dostmann W; Genieser HG; Butt E; Jastorff B
Dev Biol; 1989 May; 133(1):58-66. PubMed ID: 2540053
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide impacts bovine sperm capacitation in a cGMP-dependent and cGMP-independent manner.
Maciel VL; Caldas-Bussiere MC; Marín DFD; Paes de Carvalho CS; Quirino CR; Leal ACMS
Reprod Domest Anim; 2019 Dec; 54(12):1612-1620. PubMed ID: 31549441
[TBL] [Abstract][Full Text] [Related]
10. The commonly used cGMP-dependent protein kinase type I (cGKI) inhibitor Rp-8-Br-PET-cGMPS can activate cGKI in vitro and in intact cells.
Valtcheva N; Nestorov P; Beck A; Russwurm M; Hillenbrand M; Weinmeister P; Feil R
J Biol Chem; 2009 Jan; 284(1):556-562. PubMed ID: 19008225
[TBL] [Abstract][Full Text] [Related]
11. Regulation of intracellular Ca2+ and calcineurin by NO/PKG in proliferation of vascular smooth muscle cells.
Li SJ; Sun NL
Acta Pharmacol Sin; 2005 Mar; 26(3):323-8. PubMed ID: 15715928
[TBL] [Abstract][Full Text] [Related]
12. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries.
Jackson WF
Pharmacology; 1996 Apr; 52(4):226-34. PubMed ID: 8841085
[TBL] [Abstract][Full Text] [Related]
13. Effect of cGMP analogues and protein kinase G blocker on secretory activity, apoptosis and the cAMP/protein kinase A system in porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Pivko J; Kotwica J; Genieser H; Bulla J
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):1-9. PubMed ID: 11074350
[TBL] [Abstract][Full Text] [Related]
14. A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3A.
Hung SH; Liu AH; Pixley RA; Francis P; Williams LD; Matsko CM; Barnes KD; Sivendran S; Colman RF; Colman RW
Bioorg Chem; 2008 Jun; 36(3):141-7. PubMed ID: 18394675
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of cGMP-dependent protein kinase Iβ cyclic nucleotide-binding-B domain : Rp-cGMPS complex reveals an apo-like, inactive conformation.
Campbell JC; VanSchouwen B; Lorenz R; Sankaran B; Herberg FW; Melacini G; Kim C
FEBS Lett; 2017 Jan; 591(1):221-230. PubMed ID: 27914169
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase.
Rothermel JD; Parker Botelho LH
Biochem J; 1988 May; 251(3):757-62. PubMed ID: 2843164
[TBL] [Abstract][Full Text] [Related]
17. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
[TBL] [Abstract][Full Text] [Related]
18. Diastereomers of adenosine 3',5'-monothionophosphate (cAMP[S]) antagonize the activation of cGMP-dependent protein kinase.
Hofmann F; Gensheimer HP; Landgraf W; Hullin R; Jastorff B
Eur J Biochem; 1985 Jul; 150(1):85-8. PubMed ID: 2990928
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [(3)H]3',5'-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles.
Boadu E; Vaskinn S; Sundkvist E; Jaeger R; Sager G
Biochem Pharmacol; 2001 Aug; 62(4):425-9. PubMed ID: 11448451
[TBL] [Abstract][Full Text] [Related]
20. Intrathecally administered cGMP-dependent protein kinase Ialpha inhibitor significantly reduced the threshold for isoflurane anesthesia: implication for a novel role of cGMP-dependent protein kinase Ialpha.
Tao YX; Hassan A; Johns RA
Anesthesiology; 2000 Feb; 92(2):493-9. PubMed ID: 10691237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
